Optimizing Cotreatment of HCV and HIV Infection

This comprehensive program on managing HCV/HIV coinfection features an Interactive Decision Support Tool to compare your treatment choices with guideline recommendations an educational module with accompanying downloadable slideset for fast and efficient learning and more.

Share

Program Content

Activities

Eliminating HCV in PLWH
Can We Eliminate HCV Infection in Persons Living With HIV?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2018

Expires: November 07, 2019

HCV Drug Interactions in PLWH
How I Approach Potential Drug–Drug Interactions in My Patients With HIV-1 Infection Starting HCV Therapy
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2018

Expires: December 11, 2019

ART/DAA Interactions in PLWH
How I Avoid Interactions Between Boosted ART and HCV Therapy in My Coinfected Patients
Case Challenge
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 25, 2019

Expires: January 24, 2020

No activities added yet

No activities added yet

Faculty

cover img faculity

Annie Luetkemeyer, MD

Associate Professor of Medicine
Division of HIV, ID, & Global Medicine
San Francisco General Hospital
University of California, San Francisco
San Francisco, California

cover img faculity

Susanna Naggie, MD

Infectious Diseases Fellow
Department of Internal Medicine, Division of Infectious Diseases
Duke University Medical Center
Durham, North Carolina

cover img faculity

Mark S. Sulkowski, MD

Associate Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Provided by

ProCE Banner

Supporters

Supported by an independent educational grant from

Gilead